FRED HUTCHINSON CANCER CENTER
๐บ๐ธUnited States
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
Phase 2
Completed
- Conditions
- First Posted Date
- 2004-02-16
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00027924
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
- First Posted Date
- 2004-02-12
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00004157
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Phase 3
Completed
- Conditions
- Acute Lymphoblastic Leukemia in RemissionRefractory Hodgkin LymphomaWaldenstrom MacroglobulinemiaAcute Myeloid Leukemia in RemissionAggressive Non-Hodgkin LymphomaChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveHematopoietic and Lymphoid Cell NeoplasmDiffuse Large B-Cell LymphomaIndolent Non-Hodgkin LymphomaMantle Cell Lymphoma
- Interventions
- First Posted Date
- 2004-01-12
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 87
- Registration Number
- NCT00075478
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
๐บ๐ธVA Puget Sound Health Care System, Seattle, Washington, United States
๐ฉ๐ชMedizinische Univ Klinik Koln, Koln, Germany
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-12-31
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00006480
- Locations
- ๐บ๐ธ
Cancer Center and Beckman Research Institute, City of Hope, Duarte, California, United States
๐บ๐ธFred Hutchinson Cancer Research Center, Seattle, Washington, United States
Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Phase 1
Completed
- Conditions
- Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Previously Treated Myelodysplastic SyndromesRefractory Anemia With Excess BlastsAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Recurrent Adult Acute Myeloid LeukemiaSecondary Myelodysplastic SyndromesUntreated Adult Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Chronic Myelomonocytic Leukemia
- Interventions
- Radiation: iodine I 131 monoclonal antibody BC8Radiation: total-body irradiationProcedure: allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantationDrug: fludarabine phosphateDrug: cyclosporineDrug: mycophenolate mofetilOther: laboratory biomarker analysis
- First Posted Date
- 2003-12-12
- Last Posted Date
- 2019-11-13
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 79
- Registration Number
- NCT00008177
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 2
Completed
- Conditions
- Nodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Marginal Zone LymphomaWaldenstrรถm MacroglobulinemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueRecurrent Adult Burkitt LymphomaRecurrent Adult Lymphoblastic Lymphoma
- Interventions
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 111
- Registration Number
- NCT00073918
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT00073931
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-11-11
- Last Posted Date
- 2010-06-17
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00006367
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
๐บ๐ธMayo Clinic Cancer Center, Rochester, Minnesota, United States
๐บ๐ธUniversity of Illinois College of Medicine, Chicago, Illinois, United States
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
Phase 2
Completed
- Conditions
- Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaHepatosplenic T-cell LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Small Lymphocytic LymphomaSmall Intestine LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult Lymphoblastic LymphomaSplenic Marginal Zone Lymphoma
- Interventions
- First Posted Date
- 2003-11-05
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT00072514
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT00003868
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath